
Arena Pharmaceuticals
Arena is now part of Pfizer.
Enterprise value
$6.7b
Share price
$99.99 ARNA
Recent deals
- Healthcare
- pharmaceutical
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $35.0m | Early VC | |
N/A | $152m | Post IPO Equity | |
$35.5m | Post IPO Equity | ||
N/A | $33.0m | Post IPO Equity | |
N/A | $79.4m | Post IPO Equity | |
* | $6.7b Valuation: $6.7b | Acquisition | |
Total Funding | $35.0m |
EUR | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | (14 %) | 4378 % | - | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | (357 %) | (783 %) | 62 % | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (433 %) | (161 %) | 49 % | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | - | 225 % | 550 % | 27 % | - | - |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Arena Pharmaceuticals
Edit
ACQUISITION by Lundbeck Oct 2024